Caroline Dutriaux

Centre Hospitalier Universitaire de Bordeaux

Publishes on Melanoma and MAPK Pathways, Cancer Immunotherapy and Biomarkers, Cutaneous Melanoma Detection and Management. 382 papers and 18.2k citations.

PubIndex Score84Top 16% · mid-careerHow it's scored

382Publications

18.2kTotal Citations

First publication: 2005First senior author: 2017

Melanoma and MAPK Pathways Cancer Immunotherapy and Biomarkers Cutaneous Melanoma Detection and Management CAR-T cell therapy research Nonmelanoma Skin Cancer Studies

Top publicationsby citations

Nivolumab in Previously Untreated Melanoma without BRAF Mutation

Caroline Robert, Paolo A. Ascierto, Georgina V. Long et al.|New England Journal of Medicine|2014

Cited by 5.3k

Combined Vemurafenib and Cobimetinib in BRAF -Mutated Melanoma

James Larkin, Antoni Ribas, Paolo A. Ascierto et al.|New England Journal of Medicine|2014

Cited by 2k

Adjuvant Dabrafenib plus Trametinib in Stage IIIBRAF-Mutated Melanoma

Georgina V. Long, John M. Kirkwood, Axel Hauschild et al.|New England Journal of Medicine|2017

Cited by 1.5k

Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial

Reinhard Dummer, Keith T. Flaherty, Paolo A. Ascierto et al.|The Lancet Oncology|2018

Cited by 1k

Cobimetinib combined with vemurafenib in advanced BRAFV600-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial

Paolo A. Ascierto, James Larkin, Grant A. McArthur et al.|The Lancet Oncology|2016

Cited by 1k